- Home
- CRT vs SRTS Comparison
CRT vs SRTS Comparison
Compare CRT & SRTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | CRT | SRTS |
|---|---|---|
| Founded | 1991 | 2010 |
| Country | United States | United States |
| Employees | 2 | N/A |
| Industry | Oil & Gas Production | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 59.8M | 65.5M |
| IPO Year | N/A | 2016 |
Fundamental Metrics
Financial Performance| Metric | CRT | SRTS |
|---|---|---|
| Price | $10.74 | $3.96 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $7.00 |
| AVG Volume (30 Days) | 27.0K | ★ 32.6K |
| Earning Date | 04-14-2026 | 05-07-2026 |
| Dividend Yield | ★ 5.29% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $27,482,000.00 |
| Revenue This Year | N/A | $2.00 |
| Revenue Next Year | N/A | $34.23 |
| P/E Ratio | $11.55 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $7.07 | $3.03 |
| 52 Week High | $11.10 | $5.92 |
Technical Indicators
Market Signals| Indicator | CRT | SRTS |
|---|---|---|
| Relative Strength Index (RSI) | 54.91 | 43.88 |
| Support Level | $10.05 | $3.66 |
| Resistance Level | $11.08 | $4.60 |
| Average True Range (ATR) | 0.35 | 0.23 |
| MACD | -0.03 | -0.02 |
| Stochastic Oscillator | 64.06 | 23.40 |
Price Performance
Historical ComparisonAbout CRT Cross Timbers Royalty Trust
Cross Timbers Royalty Trust is a United States-based trust. The net profits interests are derived from producing royalty, overriding royalty interests, and working interest properties. The underlying properties of the trust include producing properties in Texas, Oklahoma, and New Mexico.
About SRTS Sensus Healthcare Inc.
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.